Jaime Guevara-Aguirre Selected Research

Neoplasms (Cancer)

1/2022	Growth hormone modulates Trypanosoma cruzi infection in vitro.
1/2022	Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement.
1/2021	Insights from the clinical phenotype of subjects with Laron syndrome in Ecuador.
1/2018	GH and GHR signaling in human disease.
1/2015	Obesity, diabetes and cancer: insight into the relationship from a cohort with growth hormone receptor deficiency.
3/2014	Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population.
2/2011	Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jaime Guevara-Aguirre Research Topics

Disease

11	Insulin Resistance 01/2021 - 02/2011
7	Neoplasms (Cancer) 01/2022 - 02/2011
6	Obesity 01/2020 - 03/2012
4	Laron Syndrome (Syndrome, Laron) 01/2018 - 06/2007
3	Type 2 Diabetes Mellitus (MODY) 01/2018 - 02/2004
2	Diabetes Mellitus 08/2020 - 01/2016
1	Carcinogenesis 01/2022
1	Chagas Disease (American Trypanosomiasis) 01/2022
1	Cognitive Dysfunction 01/2022
1	Glucose Intolerance 08/2020
1	Chronic Pain 06/2019
1	Substance-Related Disorders (Drug Abuse) 06/2019
1	Hyperinsulinism (Hyperinsulinemia) 01/2018
1	Overnutrition 01/2015
1	Inborn Genetic Diseases (Disease, Hereditary) 05/2014
1	Melanoma (Melanoma, Malignant) 03/2014
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 03/2012
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2012
1	Insulin-Like Growth Factor I Deficiency 03/2008
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2007
1	Hypoglycemia (Reactive Hypoglycemia) 02/2006
1	Body Weight (Weight, Body) 02/2006
1	Growth Disorders 02/2002

Drug/Important Bio-Agent (IBA)

14	Insulin (Novolin)FDA Link 01/2021 - 02/2004
10	Insulin-Like Growth Factor I (IGF-1)IBA 01/2022 - 02/2006
6	Growth Hormone (Somatotropin)IBA 01/2022 - 03/2008
4	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 02/2004
3	Insulin-Like PeptidesIBA 01/2022 - 02/2006
3	Oral SpraysIBA 08/2007 - 02/2004
2	Somatotropin Receptors (Growth Hormone Receptor)IBA 01/2021 - 05/2014
2	LeptinIBA 07/2015 - 02/2002
1	Tramadol (K315)FDA LinkGeneric 06/2019
1	Aromatic Amino Acids (Aromatic Amino Acid)IBA 01/2019
1	Peptides (Polypeptides)IBA 01/2018
1	Indicators and Reagents (Reagents)IBA 07/2015
1	Branched-Chain Amino AcidsIBA 07/2015
1	AdipokinesIBA 07/2015
1	AdiponectinIBA 07/2015
1	Proteins (Proteins, Gene)FDA Link 03/2014
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 02/2011
1	Codon (Codons)IBA 03/2008
1	Insulin-Like Growth Factor Binding Protein 3IBA 06/2007
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2004
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 02/2004

Therapy/Procedure

1	Protein-Restricted Diet (Diet, Protein Restricted) 03/2014
1	Injections 11/2004
1	Therapeutics 02/2004